The event will form part of the multi-track conference, Advances in Drug Discovery, and will run alongside three additional tracks: Epigenetics in Drug Discovery, Academic Drug Discovery and Stem Cells in Drug Discovery. Attendees will benefit from unrestricted access to all four conference tracks.
Attracting researchers, academics and industry professionals working in antibody research, this track will fully explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics. Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research.
If you work in antibody drug discovery research you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of antibody discovery, whilst networking with the technology providers who are enabling them to do so.
For more information please see here.